
### [MONDO:0015145](http://purl.obolibrary.org/obo/MONDO_0015145)
**Label:** Neurovascular malformation

**Subclasses:** [MONDO:0010880](http://purl.obolibrary.org/obo/MONDO_0010880) (telangiectasia, hereditary hemorrhagic, type 2), [MONDO:0012443](http://purl.obolibrary.org/obo/MONDO_0012443) (ANIB4), [MONDO:0018145](http://purl.obolibrary.org/obo/MONDO_0018145) (congenital retinal arteriovenous communication), [MONDO:0019972](http://purl.obolibrary.org/obo/MONDO_0019972) (dural sinus malformation), [MONDO:0016483](http://purl.obolibrary.org/obo/MONDO_0016483) (intracranial berry aneurysm), [MONDO:0020048](http://purl.obolibrary.org/obo/MONDO_0020048) (internal carotid agenesis), [MONDO:0015196](http://purl.obolibrary.org/obo/MONDO_0015196) (vein of Galen aneurysm), [MONDO:0008501](http://purl.obolibrary.org/obo/MONDO_0008501) (Sturge-Weber syndrome), [MONDO:0019196](http://purl.obolibrary.org/obo/MONDO_0019196) (Foix-Alajouanine syndrome), [MONDO:0019180](http://purl.obolibrary.org/obo/MONDO_0019180) (hereditary hemorrhagic telangiectasia), [MONDO:0012949](http://purl.obolibrary.org/obo/MONDO_0012949) (ANIB9), [MONDO:0011676](http://purl.obolibrary.org/obo/MONDO_0011676) (PHACE syndrome), [MONDO:0013654](http://purl.obolibrary.org/obo/MONDO_0013654) (ANIB11), [MONDO:0010468](http://purl.obolibrary.org/obo/MONDO_0010468) (ANIB5), [MONDO:0012053](http://purl.obolibrary.org/obo/MONDO_0012053) (ANIB2), [MONDO:0012194](http://purl.obolibrary.org/obo/MONDO_0012194) (ANIB3), [MONDO:0018893](http://purl.obolibrary.org/obo/MONDO_0018893) (Cobb syndrome), [MONDO:0000821](http://purl.obolibrary.org/obo/MONDO_0000821) (cerebral cavernous malformation 3), [MONDO:0019101](http://purl.obolibrary.org/obo/MONDO_0019101) (retinal capillary malformation), [MONDO:0018892](http://purl.obolibrary.org/obo/MONDO_0018892) (Wyburn-Mason syndrome), [MONDO:0008535](http://purl.obolibrary.org/obo/MONDO_0008535) (telangiectasia, hereditary hemorrhagic, of Rendu, Osler, and Weber), [MONDO:0007116](http://purl.obolibrary.org/obo/MONDO_0007116) (hereditary neurocutaneous malformation), [MONDO:0007111](http://purl.obolibrary.org/obo/MONDO_0007111) (ANIB1), [MONDO:0007672](http://purl.obolibrary.org/obo/MONDO_0007672) (Glomuvenous malformation), [MONDO:0012810](http://purl.obolibrary.org/obo/MONDO_0012810) (ANIB7), [MONDO:0007154](http://purl.obolibrary.org/obo/MONDO_0007154) (arteriovenous malformations of the brain), [MONDO:0015407](http://purl.obolibrary.org/obo/MONDO_0015407) (cerebrofacial arteriovenous metameric syndrome type 3), [MONDO:0012950](http://purl.obolibrary.org/obo/MONDO_0012950) (ANIB10), [MONDO:0012532](http://purl.obolibrary.org/obo/MONDO_0012532) (HHT4), [MONDO:0012752](http://purl.obolibrary.org/obo/MONDO_0012752) (ANIB6), [MONDO:0014217](http://purl.obolibrary.org/obo/MONDO_0014217) (telangiectasia, hereditary hemorrhagic, type 5), [MONDO:0010996](http://purl.obolibrary.org/obo/MONDO_0010996) (HHT3), [MONDO:0011305](http://purl.obolibrary.org/obo/MONDO_0011305) (cerebral cavernous malformations 3), [MONDO:0015406](http://purl.obolibrary.org/obo/MONDO_0015406) (cerebrofacial arteriovenous metameric syndrome type 1), [MONDO:0015405](http://purl.obolibrary.org/obo/MONDO_0015405) (cerebrofacial arteriovenous metameric syndrome), [MONDO:0007291](http://purl.obolibrary.org/obo/MONDO_0007291) (familial cerebral cavernous malformation), [MONDO:0012811](http://purl.obolibrary.org/obo/MONDO_0012811) (ANIB8), [MONDO:0011304](http://purl.obolibrary.org/obo/MONDO_0011304) (cerebral cavernous malformation 2), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0061053](http://purl.obolibrary.org/obo/GO_0061053) (somite development), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0050431](http://purl.obolibrary.org/obo/GO_0050431) (transforming growth factor beta binding), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0001664](http://purl.obolibrary.org/obo/GO_0001664) (G-protein coupled receptor binding), [GO:0009948](http://purl.obolibrary.org/obo/GO_0009948) (anterior/posterior axis specification), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0050715](http://purl.obolibrary.org/obo/GO_0050715) (positive regulation of cytokine secretion), [GO:2000352](http://purl.obolibrary.org/obo/GO_2000352) (negative regulation of endothelial cell apoptotic process), [GO:0047391](http://purl.obolibrary.org/obo/GO_0047391) (alkylglycerophosphoethanolamine phosphodiesterase activity), [GO:0070208](http://purl.obolibrary.org/obo/GO_0070208) (protein heterotrimerization), [GO:2000114](http://purl.obolibrary.org/obo/GO_2000114) (regulation of establishment of cell polarity), [GO:0036122](http://purl.obolibrary.org/obo/GO_0036122) (BMP binding), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0004675](http://purl.obolibrary.org/obo/GO_0004675) (transmembrane receptor protein serine/threonine kinase activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0031464](http://purl.obolibrary.org/obo/GO_0031464) (Cul4A-RING E3 ubiquitin ligase complex), [GO:0031462](http://purl.obolibrary.org/obo/GO_0031462) (Cul2-RING ubiquitin ligase complex), [GO:0031463](http://purl.obolibrary.org/obo/GO_0031463) (Cul3-RING ubiquitin ligase complex), [GO:0032434](http://purl.obolibrary.org/obo/GO_0032434) (regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:0005171](http://purl.obolibrary.org/obo/GO_0005171) (hepatocyte growth factor receptor binding), [GO:0031461](http://purl.obolibrary.org/obo/GO_0031461) (cullin-RING ubiquitin ligase complex), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045669](http://purl.obolibrary.org/obo/GO_0045669) (positive regulation of osteoblast differentiation), [GO:0060389](http://purl.obolibrary.org/obo/GO_0060389) (pathway-restricted SMAD protein phosphorylation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0048264](http://purl.obolibrary.org/obo/GO_0048264) (determination of ventral identity), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001885](http://purl.obolibrary.org/obo/GO_0001885) (endothelial cell development), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001886](http://purl.obolibrary.org/obo/GO_0001886) (endothelial cell morphogenesis), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0055105](http://purl.obolibrary.org/obo/GO_0055105) (ubiquitin-protein transferase inhibitor activity), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0035412](http://purl.obolibrary.org/obo/GO_0035412) (regulation of catenin import into nucleus), [GO:0042327](http://purl.obolibrary.org/obo/GO_0042327) (positive regulation of phosphorylation), [GO:0043534](http://purl.obolibrary.org/obo/GO_0043534) (blood vessel endothelial cell migration), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0040029](http://purl.obolibrary.org/obo/GO_0040029) (regulation of gene expression, epigenetic), [GO:0021884](http://purl.obolibrary.org/obo/GO_0021884) (forebrain neuron development), [GO:0030513](http://purl.obolibrary.org/obo/GO_0030513) (positive regulation of BMP signaling pathway), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0042692](http://purl.obolibrary.org/obo/GO_0042692) (muscle cell differentiation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0072359](http://purl.obolibrary.org/obo/GO_0072359) (circulatory system development), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0043267](http://purl.obolibrary.org/obo/GO_0043267) (negative regulation of potassium ion transport), [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0045603](http://purl.obolibrary.org/obo/GO_0045603) (positive regulation of endothelial cell differentiation), [GO:0007215](http://purl.obolibrary.org/obo/GO_0007215) (glutamate receptor signaling pathway), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0045602](http://purl.obolibrary.org/obo/GO_0045602) (negative regulation of endothelial cell differentiation), [GO:0032924](http://purl.obolibrary.org/obo/GO_0032924) (activin receptor signaling pathway), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0001508](http://purl.obolibrary.org/obo/GO_0001508) (action potential), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:2000279](http://purl.obolibrary.org/obo/GO_2000279) (negative regulation of DNA biosynthetic process), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0005160](http://purl.obolibrary.org/obo/GO_0005160) (transforming growth factor beta receptor binding), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0048845](http://purl.obolibrary.org/obo/GO_0048845) (venous blood vessel morphogenesis), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0007188](http://purl.obolibrary.org/obo/GO_0007188) (adenylate cyclase-modulating G-protein coupled receptor signaling pathway), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0045454](http://purl.obolibrary.org/obo/GO_0045454) (cell redox homeostasis), [GO:0007189](http://purl.obolibrary.org/obo/GO_0007189) (adenylate cyclase-activating G-protein coupled receptor signaling pathway), [GO:0060158](http://purl.obolibrary.org/obo/GO_0060158) (phospholipase C-activating dopamine receptor signaling pathway), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0060039](http://purl.obolibrary.org/obo/GO_0060039) (pericardium development), [GO:0032757](http://purl.obolibrary.org/obo/GO_0032757) (positive regulation of interleukin-8 production), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0031826](http://purl.obolibrary.org/obo/GO_0031826) (type 2A serotonin receptor binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0030695](http://purl.obolibrary.org/obo/GO_0030695) (GTPase regulator activity), [GO:0016322](http://purl.obolibrary.org/obo/GO_0016322) (neuron remodeling), [GO:0010862](http://purl.obolibrary.org/obo/GO_0010862) (positive regulation of pathway-restricted SMAD protein phosphorylation), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0061036](http://purl.obolibrary.org/obo/GO_0061036) (positive regulation of cartilage development), [GO:0007033](http://purl.obolibrary.org/obo/GO_0007033) (vacuole organization), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0061154](http://purl.obolibrary.org/obo/GO_0061154) (endothelial tube morphogenesis), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0006469](http://purl.obolibrary.org/obo/GO_0006469) (negative regulation of protein kinase activity), [GO:0005138](http://purl.obolibrary.org/obo/GO_0005138) (interleukin-6 receptor binding), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0034405](http://purl.obolibrary.org/obo/GO_0034405) (response to fluid shear stress), [GO:0007043](http://purl.obolibrary.org/obo/GO_0007043) (cell-cell junction assembly), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007202](http://purl.obolibrary.org/obo/GO_0007202) (activation of phospholipase C activity), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0007200](http://purl.obolibrary.org/obo/GO_0007200) (phospholipase C-activating G-protein coupled receptor signaling pathway), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:0005025](http://purl.obolibrary.org/obo/GO_0005025) (transforming growth factor beta receptor activity, type I), [GO:0045634](http://purl.obolibrary.org/obo/GO_0045634) (regulation of melanocyte differentiation), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0045086](http://purl.obolibrary.org/obo/GO_0045086) (positive regulation of interleukin-2 biosynthetic process), [GO:0072554](http://purl.obolibrary.org/obo/GO_0072554) (blood vessel lumenization), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0042130](http://purl.obolibrary.org/obo/GO_0042130) (negative regulation of T cell proliferation), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), 

**Class expressions from DL-Learner:**

- Thing 54.57%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.98%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.98%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.34%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004218](http://purl.obolibrary.org/obo/GO_0004218) (obsolete cathepsin S activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004217](http://purl.obolibrary.org/obo/GO_0004217) (obsolete cathepsin L activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004216](http://purl.obolibrary.org/obo/GO_0004216) (obsolete cathepsin K activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004215](http://purl.obolibrary.org/obo/GO_0004215) (obsolete cathepsin H activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004214](http://purl.obolibrary.org/obo/GO_0004214) (obsolete dipeptidyl-peptidase I activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004213](http://purl.obolibrary.org/obo/GO_0004213) (obsolete cathepsin B activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004212](http://purl.obolibrary.org/obo/GO_0004212) (obsolete lysosomal cysteine-type endopeptidase) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004211](http://purl.obolibrary.org/obo/GO_0004211) (obsolete caspase-9 activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004210](http://purl.obolibrary.org/obo/GO_0004210) (obsolete caspase-7 activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0004209](http://purl.obolibrary.org/obo/GO_0004209) (obsolete caspase-6 activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.34%


